DHR vs MAR: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Marriott International, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
VS
Marriott International, Inc. · Consumer Cyclical
$396.20
-13.1% upside to fair value
Grade D
QuantHub Verdict
DHR has more upside to fair value
(+8.9%).
DHR trades at a lower forward P/E
(34.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
MAR |
| Current Price |
$177.17 |
$396.20 |
| Fair Value Estimate |
$192.90 |
$344.12 |
| Upside to Fair Value |
+8.9%
|
-13.1%
|
| Market Cap |
$125.4B |
$104.5B |
| Forward P/E |
34.1x
|
41.6x
|
| EV / EBITDA |
20.8x
|
25.5x
|
| Price / Sales |
5.1x
|
3.9x
|
| Price / FCF |
23.7x
|
33.5x
|
| Revenue Growth YoY |
+3.7%
|
+6.2%
|
| Gross Margin |
60.7%
|
21.4%
|
| Operating Margin |
21.0%
|
16.0%
|
| Return on Equity |
7.1%
|
-74.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.22%
|
2.98%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
Marriott International operates as a leading global fee-based, asset-light hotel franchisor and manager with a strong brand portfolio and a durable competitive moat driven by its global scale and loyalty program. The company benefits from high-margin recurring fee revenue, which supports stable cash flow and robust capital returns exceeding $4 billion annually. Despite solid revenue growth of 6.2…
Accumulation Zones
| Metric |
DHR |
MAR |
| Zone Low |
$144.68 |
$258.09 |
| Zone High |
$163.97 |
$292.50 |
| In Buy Zone? |
No
|
No
|